Matches in Nanopublications for { ?s ?p "[The high prevalence of KRAS mutations and importance of the RalGEF-Ral pathway downstream of activated K-ras in pancreatic ductal adenocarcinoma (PDAC) emphasize the importance of identifying novel methods by which to therapeutically target these pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP528121.RA1kubjkePTj59MWyCG8YhUn4Dge5xdrcwEkzAFuygYrA130_assertion description "[The high prevalence of KRAS mutations and importance of the RalGEF-Ral pathway downstream of activated K-ras in pancreatic ductal adenocarcinoma (PDAC) emphasize the importance of identifying novel methods by which to therapeutically target these pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP528121.RA1kubjkePTj59MWyCG8YhUn4Dge5xdrcwEkzAFuygYrA130_provenance.
- NP1127489.RA28Ds9SB5g_cV5eYrV5rA3IJ1hHmPTjjF4qk--etDB_g130_assertion description "[The high prevalence of KRAS mutations and importance of the RalGEF-Ral pathway downstream of activated K-ras in pancreatic ductal adenocarcinoma (PDAC) emphasize the importance of identifying novel methods by which to therapeutically target these pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1127489.RA28Ds9SB5g_cV5eYrV5rA3IJ1hHmPTjjF4qk--etDB_g130_provenance.
- assertion description "[The high prevalence of KRAS mutations and importance of the RalGEF-Ral pathway downstream of activated K-ras in pancreatic ductal adenocarcinoma (PDAC) emphasize the importance of identifying novel methods by which to therapeutically target these pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The high prevalence of KRAS mutations and importance of the RalGEF-Ral pathway downstream of activated K-ras in pancreatic ductal adenocarcinoma (PDAC) emphasize the importance of identifying novel methods by which to therapeutically target these pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP665016.RAlwCuWVtTuHIe2NtaHQu1Y-GHVAzg4BMQHSzCiVxzPEc130_assertion description "[The high prevalence of KRAS mutations and importance of the RalGEF-Ral pathway downstream of activated K-ras in pancreatic ductal adenocarcinoma (PDAC) emphasize the importance of identifying novel methods by which to therapeutically target these pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665016.RAlwCuWVtTuHIe2NtaHQu1Y-GHVAzg4BMQHSzCiVxzPEc130_provenance.
- NP1127488.RAgIfFB5uDkUMjHsq0ZYVd2M9aKsSMut_sr1xR-6wYYo4130_assertion description "[The high prevalence of KRAS mutations and importance of the RalGEF-Ral pathway downstream of activated K-ras in pancreatic ductal adenocarcinoma (PDAC) emphasize the importance of identifying novel methods by which to therapeutically target these pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1127488.RAgIfFB5uDkUMjHsq0ZYVd2M9aKsSMut_sr1xR-6wYYo4130_provenance.